The prevalence of restless legs syndrome (RLS) and its association with the clinical features of Behçet's disease (BD) has not previously been elucidated. The inflammatory character, central nervous system involvement and neuropathies of BD led to this investigation of RLS risk in BD patients. A total of 116 BD patients and 104 healthy control subjects were included; seven BD patients were excluded because of concurrent diseases, pregnancy or alcohol misuse that might cause RLS symptoms, and the remaining 109 BD patients were included in the analysis. The prevalence of RLS was significantly higher in patients with BD (32/109; 29.4%) than in controls (5/104; 4.8%). No significant differences were found between BD patients with and without RLS with regard to the clinical features of BD. RLS severity positively correlated with age in BD patients. In conclusion, BD-related RLS should be considered in symptomatic RLS secondary to rheumatological disorders and BD patients should be examined for RLS. Further studies are needed to clarify the pathogenetic mechanisms underlying BD-related RLS.
Introduction
Restless legs syndrome (RLS) is a common, yet frequently underdiagnosed, chronic, sensorimotor movement disorder associated primarily with the lower extremities. 1 It is characterized by significant, uncomfortable creeping, crawling or cramping sensations at rest, and the irresistible urge to move. 2 These sensations (paraesthesias) occur or are worsened during periods of rest or inactivity, particularly in the evening and at night, and are partially or totally relieved by movement. 3 While the pathophysiology of RLS is not fully understood, local dopamine dysfunction within the central nervous system (CNS), reduced levels of cerebral iron, and cerebrospinal ferritin appear to play critical roles. 1 -3 RLS occurs more frequently in patients with rheumatic diseases, including rheumatoid arthritis (RA), Sjögren's syndrome and fibromyalgia syndrome (FMS). 4 -6 This association may be due to inflammatory processes, subclinical or clinical iron deficiency, neurochemical predisposition arising from chronic pain, or neuropathies, 1, 5, 6 although this remains unclear.
Behçet's disease (BD) is a complex, chronic, inflammatory, multisystemic autoimmune disease characterized by systemic vasculitis and perivascular inflammatory infiltrates. 7 The disorder was L Ediz, O Hiz, M Toprak et al.
RLS and Behçet's disease first described in 1937 as a triple symptom complex consisting of oral and genital aphthous ulcerations and relapsing uveitis. 8 BD also leads to organ damage involving the cardiovascular, articular, pulmonary, neurologic and gastrointestinal systems. 8 -10 Potential associations between RLS and BD have not been elucidated. Taking into account the inflammatory character of BD, the increased prevalence of FMS in BD, 11 CNS involvement, neuropathies and low ferritin levels 12 of BD, the present study was designed to investigate the prevalence of RLS, to explore potential associations with clinical features of BD, and to ascertain the prevalence of pre-existing RLS in a population with BD.
Patients and methods

PATIENTS
Patients with Behçet's disease who were admitted for rheumatology follow-up to the outpatient clinic of Yuzuncu Yil University Medical Faculty Hospital, Van, Turkey, from August 2008 to August 2010, were recruited to the study. All patients fulfilled the International Study Group for BD classification criteria. 13 Healthy age-and sex-matched control volunteer subjects were recruited from the general population by poster invitation.
Each patient underwent a structured interview on concurrent diseases or conditions that might cause RLS symptoms. Subjects with diabetes mellitus, connective tissue disease, kidney, liver or thyroid diseases, amyloidosis, chronic heart failure, malignancies, RA, or neurological diseases including Parkinson's disease or multiple sclerosis were excluded from the study. Patients who were pregnant, taking drugs that could potentially interfere with RLS and those with alcohol dependency were also excluded. There were no limitations regarding chronic BD treatments such as colchicine, cyclophosphamide, or azathioprine.
The study was approved by the Ethical Committee of Yuzuncu Yil University Medical Faculty, Van, Turkey, and all participants gave written and verbal informed consent according to the Declaration of Helsinki.
ASSESSMENT OF SYMPTOMS
A complete neurological examination was performed for all BD patients, including the evaluation of paraesthesias, muscle weakness, abnormalities of deep tendon reflexes, hypoesthesia and vibration threshold. Demographic details, duration of disease, medical history and drug intake were recorded.
Both patients and control subjects completed a data collection interview for RLS, including whether the patient/subject met the four essential diagnostic criteria for RLS 14 and, if so, whether they had sought medical attention for these symptoms and been previously diagnosed with RLS. All RLSpositive subjects were assessed with the Turkish version of the Epworth Sleepiness Scale (ESS), 15 and the severity of RLS was investigated using the International RLS Study Group rating scale (IRLSSG-RS). 16 Clinical features of BD were determined in all BD patients, and blood levels of iron, ferritin, haemoglobin and mean corpuscular volume (MCV) were assessed in BD patients, but not in control subjects, using standard techniques.
A subject was considered to be affected by RLS if they met the four essential diagnostic criteria 14 and if the frequency of symptoms was twice per week or more during the previous 6 months. On the basis of the interview data, patients with BD were classified into two groups: (i) subjects affected by BD without RLS symptoms 
Results
The study recruited 116 patients with BD and 104 healthy control subjects. The study design led to seven BD patients being excluded from the study; two due to concurrent diabetes mellitus, one due to pregnancy, one due to alcohol misuse and three due to concurrent thyroid disease. There were no significant differences in age, sex or body mass index (BMI) between BD patients and healthy controls ( Table 1 ). The prevalence of RLS was significantly higher in BD patients than in healthy controls (29.4% vs 4.8%, P < 0.001, Table 2 ). Only 4/32 (12.5%; 18 women and 14 men) BD/RLS patients indicated that they had sought medical attention for RLS symptoms. No significant differences were found Table 2) . No significant differences were found between BD/RLS and BD/non-RLS patients with regard to sex, age, BMI and clinical features of BD (Table 3 ). Blood levels of iron and ferritin, and MCV, were also not significantly different between BD/RLS and BD/non-RLS groups ( Table 3 ).
There was no correlation between RLS severity and gender, BMI, BD clinical features, and blood levels of iron, ferritin, haemoglobin and MCV. RLS severity was significantly and positively correlated with age in BD/RLS patients (r = 0.56; P = 0.027).
Discussion
The present study demonstrated that a relatively high proportion of BD patients (29.4%) in this population had RLS compared with controls. Only 4.8% of the healthy Turkish control population included in the present study had RLS. To our knowledge this is the first study demonstrating an increased prevalence of RLS in patients with BD. The prevalence of RLS has been reported to be between 3% and 12% in general Western populations, 1,2 and 3.4% in a Turkish population screened according to the criteria for RLS published by the IRLSSG. 17 Previous studies have reported an increase in the prevalence of RLS in some rheumatological conditions, including RA. Reynolds et al. 18 found the prevalence of RLS in patients hospitalized for RA was 30%, compared with 6% in control subjects, but this study did not evaluate iron deficiency, anaemia, or renal failure. Similar findings 19 and Taylor-Gjevre et al. 5 In spite of improved treatment options, RLS is a common syndrome, although still relatively unrecognized among both physicians and the general public. 20 Only 12.5% of BD patients included in the present study who were symptomatic for RLS reported seeking medical attention for these symptoms.
The relationship between BD and RLS remains unclear. Decreased brain iron and low serum ferritin are well recognized pathological features of RLS, 21 and iron is a necessary cofactor for the synthesis of dopamine. 22 With use of non-steroidal antiinflammatory drugs (NSAIDs) being common in patients with BD (for arthralgias and chronic pain states), it is possible that subclinical iron deficiency may be common. Because 60 -70% of patients on long-term NSAID therapy develop small intestine inflammation and intestinal bleeding (intestinal blood loss), which is usually between 2 and 10 ml/day, 23 and because a high frequency of unusual gastric/duodenal ulcers and intestinal inflammation occurs due to BD itself, 24 there may be an increased risk for subclinical iron deficiency in patients with BD. 23, 24 In a previous study, the prevalence of low serum ferritin and iron levels was found to be approximately 15% in patients with BD, 12 compared with 4.7% in the general population. 25 The present study, however, demonstrated no difference between BD/RLS patients and BD/non-RLS patients in terms of iron and ferritin deficiency.
An alternative hypothesis for the connection between BD and RLS is a neurochemical predisposition arising from chronic pain conditions. Dopaminergic abnormalities have been hypothesized in the aetiology of RLS. 26 Stehlik et al. 6 found that 64% of patients diagnosed with FMS (a rheumatological and chronic pain condition) were also affected by RLS, and FMS prevalence is markedly increased in patients with BD. 11 It has been postulated that FMS and RLS may possess a similar pathophysiology, such as a dysfunction of the CNS dopaminergic system. 6 In addition, Wood et al. 27 recently used positron emission tomography to demonstrate that FMS patients have an abnormal dopamine response to pain. Dopaminergic cells have been found to have potentially nociceptive functional capacity, 28 -30 and CNS involvement in BD may result in a dysfunction of the CNS dopaminergic system. 31 These observations and suggestions indicate a possible link between chronic pain and RLS predisposition in patients with BD. RLS is common in cases of acquired polyneuropathy, 32 and BD is known to induce neuropathy, 33, 34 suggesting that BD and RLS may be related via BD-induced polyneuropathy.
The present study found no relationship between the severity of RLS (as determined by IRLSSG-RS questionnaire) and gender, BMI, clinical features of BD, or blood levels of iron, ferritin, haemoglobin, and MCV. Age alone was positively correlated with RLS severity in BD/RLS patients. This finding is consistent with the fact that the prevalence of RLS in the general population increases with age. 35 In conclusion, BD-related RLS should be considered in symptomatic RLS secondary to rheumatological disorders, and BD patients should be examined for RLS. Further studies are needed to clarify the features and pathogenetic mechanisms underlying BDrelated RLS.
